Abstract We examined differences in time to diagnosis by race/ethnicity, the relationship between time to diagnosis and stage, and the extent to which it explains differences in stage at diagnosis across racial/ethnic groups. Our analytic sample includes 21,427 non-Hispanic White (White), Hispanic, non-Hispanic Black (Black) and non-Hispanic Asian/Pacific Islander (Asian) women diagnosed with stage I to IV breast cancer between
Introduction
Stage at diagnosis is a strong predictor of breast cancer mortality. Five-year survival rates are better for early stage (88 % for women diagnosed at stage I and 78 % for diagnoses at stage II) than for advanced stage (15 % for diagnoses at stage IV) [1] . Non-Hispanic Whites and Asians are more likely to be diagnosed at early stages than Hispanics and Blacks. While 62.3 % of Whites and 62.5 % of Asian/ Pacific Islanders are diagnosed with localized stage tumors, only 53.8 % of Hispanics and 51.9 % of Blacks have the same diagnostics [1] .
Longer time between the onset of symptoms or detection of a breast abnormality via mammography has been hypothesized to be associated with later-stage diagnosis [2, 3] . Yet, few studies assessing delays in diagnosis have included racial/ ethnic groups other than Blacks and Whites [4] [5] [6] [7] [8] [9] . Studies have also focused on limited geographic areas and used patients diagnosed in the 1980s and 1990s [10] . There have been important reforms in coverage of breast cancer screening and treatment since the 1990s, including expansion of National Breast and Cervical Cancer Early Detection Program, which provides care for lower income women and has set goals for timely diagnostic resolution of abnormal mammograms. It is important to examine the relationship between delay, stage and race among more recently diagnosed women. Racial or ethnic variation in delay, or whether delay explains variation in stage and ultimately survival by race/ethnicity, has not been addressed [11, 12] . We examined the relationship between time to diagnosis and race/ethnicity, and associations between these factors and stage of disease in a multiethnic population in the United States.
Patients and methods

Study population and data collection
The National Comprehensive Cancer Network (NCCN) Breast Cancer Outcomes Database has collected prospective data on patient and tumor characteristics, sociodemographic information, treatment and outcomes for women receiving care for newly diagnosed breast cancer since 1997. The study population includes 25,510 women with new stage I-IV breast cancer diagnoses [13, 14] at each center approved the study, data collection process, data transmission methods and data storage protocols.
Tumor characteristics including estrogen and progesterone hormone (ER/PR) status and grade and treatment information are gathered from tumor registries and chart review [13, [15] [16] [17] . At most centers, patients also complete an intake survey, which elicits information about the initial sign of breast cancer, race/ethnicity, employment status, educational status and menopausal status. Study abstractors fill in missing survey data based on chart review. Data quality assurance processes have been documented [18] .
We identified 25,131 Stage I-IV patients who presented with a new diagnosis of breast cancer and received primary therapy at one of the NCCN institutions between January 1, 2000 and December 31, 2007. We excluded anyone with: a previous cancer diagnosis (n = 1,913), missing date of initial symptom/sign or reported date after patient's diagnosis of breast cancer (n = 434), missing description of or indicated ''other'' initial sign/symptom (n = 966), and missing, American Indian/Aleutian/Eskimo or 'other' race (N = 391). Our final sample included 21,427 women.
Using survey data, women were classified as Caucasian (White), African-American (Black), Asian or Pacific Islander. Ethnicity was classified as Non-Hispanic, Hispanic or Unknown. If ethnicity was unknown, women were assumed to be non-Hispanic. We then cross-classified race and ethnicity to create four categories: non-Hispanic White (White), non-Hispanic Black (Black), non-Hispanic Asian or Pacific Islander (Asian) and Hispanic.
Exposure and outcome assessment
Time to diagnosis was defined as the time from date of initial sign of breast cancer to date of breast cancer diagnosis. Date of diagnosis was date of first biopsy or diagnostic procedure. Times longer than 1 year were truncated at 365 days. Initial sign was dichotomized as either abnormal screening mammography or symptom (e.g., bloody nipple discharge, discovery of a breast lump, axillary mass, inverted nipple or breast pain/discomfort). Stage at diagnosis was characterized according to the American Joint Committee on Cancer Staging Manual (5th Edition thru January 1, 2002 or 6th edition thereafter).
Statistical analysis
We present age-standardized percentages of patient and clinical characteristics at study intake, stratified by racial/ ethnic group. Multinomial logistic (categorical variables) and binomial logistic (binary variables) regression models were used to generate age-adjusted p values. We used the Generalized Extreme Studentized Deviate Test for Outliers to examine time to diagnosis for extreme values [19] . We calculated Kaplan-Meier survival curves to examine the unadjusted relationship between time to diagnosis and race/ ethnicity by initial sign (abnormal mammogram or symptom). We used multivariable Cox proportional hazards regression to estimate hazard ratio (HR) and 95 % confidence intervals (CI) for the relationship between time to diagnosis and race/ ethnicity stratified by initial sign or symptom, after testing the proportional hazards assumption. HRs below one represent lower diagnosis rates and longer times to diagnosis; HRs above one represent higher diagnosis rates and shorter times to diagnosis.
We used multinomial logistic regression models to examine the association between time to diagnosis, race/ethnicity and breast cancer stage with stage I as the reference group. Time to diagnosis was categorized as follows: \30 days, 30-59 days, 60-89 days, 90-179 days and C180 days. Likelihood ratio tests were used to assess interactions between time to diagnosis, race and initial sign or symptom. P values are two-sided with an alpha level of 0.05. Analyses were performed using SAS version 9.2.
We adjusted for the following: age at diagnosis (in years), body mass index at presentation (kg/m [20, 21] , educational attainment (high school or less, some college, college graduate, graduate school), employment status (employed or student, retired or homemaker, unable to work/ unemployed, other), menopausal status at diagnosis (premenopausal, post-menopausal), insurance status (managed care, Medicaid, indemnity, Medicare, other/unknown) and NCCN institution.
Results
Of the 21,427 women included, 82.6 % were White, 6.4 % Black, 8.0 % Hispanic and 3.0 % Asian (Table 1 ). Time to diagnosis of less than one month occurred in the majority of NH-White women (52 %), compared to 39 % in Hispanics, 42 % of Blacks and 45 % of Asians (p \ 0.0001). Whites were more likely to have abnormal screening mammogram as their first sign of breast cancer (46 %), than Asians (32 %) or Hispanics and Blacks (35 %) (p \ 0.0001) ( Table 1) . Although most women were diagnosed with stage I or II breast cancer (73 % in Blacks to 85 % in Whites), Blacks had the highest proportion (26 %) diagnosed with Stage III or IV breast cancer (p \ 0.0001).
Across all racial/ethnic groups, women with symptoms had longer median time to diagnosis than women with abnormal mammograms (Fig. 1a, b) . Among symptomatic women, the median time to diagnosis was 36 days among Whites, 53.6 days for Blacks, 40 days for Asians and 46 days among Hispanics (Fig. 1a) . Among women with abnormal mammogram, the median time to diagnosis was 21 days among Whites, 29 days for Blacks, 28 days for Asians and 26 days among Hispanics (Fig. 1b) .
The association between race/ethnicity and time to diagnosis varied by type of initial sign of breast cancer (p-interaction = 0.01; Table 2 ); thus, we present stratified estimates. There was no difference in time to diagnosis between Asians and Whites regardless of initial sign. Among symptomatic women, after adjusting for sociodemographic and health characteristics, there was no difference between Hispanics and Whites, while Blacks had 10 % longer times to diagnosis Medicaid insurance was associated with 21 % longer time to diagnosis (HR = 0.79; 95 % CI, 0.74-0.84) as compared to those with managed care (Table 2, Model 3). Women with a college education had 6 % shorter time to diagnosis than women with a high school degree or less (HR = 1.06; 95 % CI, 1.02, 1.10). We did not find evidence of any statistical interactions between race and insurance status, tumor characteristics, education or employment status. Additional adjustment for tumor characteristics did not materially change the results (data not shown). 
Discussion
We found that Blacks, Hispanics and Asians, experienced longer times from initial sign of breast cancer to definitive diagnosis and were more likely to present with symptoms versus detected through screening mammography. Blacks and Hispanics were also more likely to be diagnosed with stage II &III/IV breast cancer when compared with Whites. Time to diagnosis did not explain racial/ethnic variation in [4, 22, 23] . Women presenting with symptoms had longer times to diagnosis and were diagnosed at later stages than women with abnormal mammograms. The difference by detection method may be due to the tendency of mammography to detect tumors of smaller size and with more favorable characteristics than tumors detected via symptoms. [24] Additionally, the start date for the calculation of time to diagnosis is likely later in the tumor development process among symptomatic women versus those with abnormal mammograms. This is consistent with our finding that time to diagnosis of C60 days was associated with increased risk of stage III/IV disease among women with symptoms while C180 days were the threshold for women with abnormal mammograms.
Access to care, individual and health system factors may also contribute to time to diagnosis in symptomatic versus screen-detected cancers [6, [25] [26] [27] . Paradoxically, among women with abnormal mammograms, those with longer times to diagnosis had lower risk of stage II diagnosis. A possible explanation for this observation might be that diagnostic follow-up occurs more quickly for high-risk groups (e.g., those with a family history of breast cancer) while women with longer time to diagnosis are those suspected by providers to have benign or less aggressive disease [3] . National Breast and Cervical Cancer Early Detection Program (NBCCEDP) guidelines aim for all women to be diagnosed within 60 days of an abnormal mammogram. Efforts to address system and individual barriers to timely follow-up include case management and patient navigation programs. Case management within NBCCEDP was associated with a 35 % decreased risk of diagnostic delay, and this effect did not differ by race/ethnicity [28] . Patient navigation strategies may be an effective strategy for decreasing delay and proportion of advanced-stage diagnoses [29, 30] . In a randomized intervention trial, Ferrante et al. [31] found that women receiving navigation services had shorter diagnostic resolution times, lower mean anxiety scores and higher mean satisfaction scores than control participants. Navigation programs may help women with abnormal mammograms, but more work must be done to reduce the burden of among symptomatic women. Seven of eight centers included in this analysis have implemented patient navigation programs, though none were in opera -tion during the entire period covered by this analysis. Had our study been conducted in centers without such programs, it is possible we could have observed even greater racial/ethnic disparities.
We were unable to account for the burden of late-stage breast cancer among NH-Black women as compared to Whites. Previous studies that have examined the relationship between breast cancer stage at diagnosis and race/ ethnicity suggest that differences may involve socioeconomic status, tumor biology and their interaction [32] [33] [34] . Blacks are generally diagnosed at younger ages and with later-stage, higher-grade and hormone receptor-negative tumors [35] [36] [37] . Blacks are also more likely to live in poverty and to have lower educational attainment relative to Whites, factors that are associated with breast cancer stage at diagnosis. Lifestyle factors and environmental exposures may be associated with tumor biology [38, 39] . When we accounted for ER, PR and tumor grade in our stage at diagnosis analysis, Blacks were still at increased risk of late-stage tumors, though the risk was somewhat attenuated. However, there are other markers that we were unable to account for and tumor biology may still play an important role in racial differences in stage at diagnosis. We could not adjust for prior mammography or other screening history (e.g., MRI, ultrasound use) in our analysis. We have stratified by initial sign as time to diagnosis may be differentially misclassified by initial sign. Date of abnormal mammogram is abstracted from medical records while date of first symptom is subject to recall. However, misclassification is unlikely to be differential with respect to our primary exposure of interest, race/ethnicity. Non-differential misclassification among symptomatic women may explain why associations were stronger for women with abnormal mammograms than for symptomatic women (Table 2 ). To reduce recall bias, women were interviewed within weeks or months of their diagnosis and patient reports were confirmed through record review when possible. Finally, the NCCN database is not population-based, and the experiences of women in this study may not be generalizable to all women with breast cancer. Patients receiving care at NCCN centers may be better at accessing the health system than the general population. They may also represent a more aggressive case mix since local providers may be more likely to refer them to large centers for care.
Educational attainment and employment status were used as surrogates of socioeconomic status. While residual confounding cannot be ruled out, it is unlikely to fully explain our results. First, higher educational attainment was associated with earlier diagnosis, and lower risk of late-stage breast cancer. Second, education and employment explained variation in stage at diagnosis among Hispanics, and misclassification of these factors is not expected to vary by race/ ethnicity. Despite these limitations, our study used recent data from over 20,000 women across the United States to examine time to diagnosis. Most prior studies on this topic have focused on black and white women; inclusion of Hispanics and Asians is another important contribution. We were also able to examine whether time to diagnosis explains variation in stage at diagnosis by race ethnicity.
We were unable to fully account for the higher risk of latestage diagnosis among NH-Black women in our study. The factors that contribute to this may include tumor characteristics which vary by race/ethnicity, biologic responses and individual risk behavior and social and institutional factors [40] . Future research to identify effective solutions will require moving beyond examining proximal causes of disease and creating interventions targeting these different factors.
